Brammer Biopharmaceutical merging with Florida Biologix

Brammer Biopharmaceuticals is merging with Florida Biologix to create Brammer Bio. Financial terms weren’t announced. Brammer Bio is a gene therapy biologics contract development and manufacturing organization. Ampersand Capital Partners owns a majority of Florida Biologix and is making an investment in the combined company.

DealsNorth AmericaUSBriefs